QS Investors, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 17 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$719,000
+29.1%
155,683
-2.2%
0.01%
+14.3%
Q4 2018$557,000
-65.3%
159,1330.0%0.01%
-53.3%
Q3 2018$1,604,000
+39.2%
159,1330.0%0.02%
+36.4%
Q2 2018$1,152,000
+19.9%
159,133
+0.0%
0.01%
+10.0%
Q1 2018$961,000
-41.6%
159,107
-7.0%
0.01%
-33.3%
Q4 2017$1,646,000
+2.8%
171,071
-5.1%
0.02%
+15.4%
Q3 2017$1,601,000
-29.8%
180,3090.0%0.01%
-31.6%
Q2 2017$2,281,000
+19.2%
180,309
-1.0%
0.02%
+18.8%
Q1 2017$1,914,000
+14.2%
182,1350.0%0.02%
+14.3%
Q4 2016$1,676,000
-21.9%
182,1350.0%0.01%
-17.6%
Q3 2016$2,147,000
-8.9%
182,1350.0%0.02%
-15.0%
Q2 2016$2,357,000
-19.1%
182,1350.0%0.02%
-28.6%
Q1 2016$2,912,000
-44.2%
182,1350.0%0.03%
-44.0%
Q4 2015$5,215,000
-1.5%
182,135
-2.1%
0.05%
-9.1%
Q3 2015$5,295,000
-21.7%
186,036
-1.2%
0.06%
-33.7%
Q2 2015$6,761,000
+23.6%
188,236
+100.0%
0.08%
+33.9%
Q1 2015$5,470,000
+37.8%
94,1180.0%0.06%
+34.8%
Q4 2014$3,969,00094,1180.05%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2019
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders